SPHK1 and colorectal carcinoma: By integrating bulk and single-cell transcriptomic data, our study demonstrates that elevated SPHK1/S1P activity in CRC cells is associated with increased pro-angiogenic function, earlier metastasis, and poorer clinical outcomes.